175 related articles for article (PubMed ID: 15182148)
1. Residual lung damage after completion of treatment for multidrug-resistant tuberculosis.
de Vallière S; Barker RD
Int J Tuberc Lung Dis; 2004 Jun; 8(6):767-71. PubMed ID: 15182148
[TBL] [Abstract][Full Text] [Related]
2. Computed tomography features of extensively drug-resistant pulmonary tuberculosis in non-HIV-infected patients.
Lee ES; Park CM; Goo JM; Yim JJ; Kim HR; Lee HJ; Lee IS; Im JG
J Comput Assist Tomogr; 2010 Jul; 34(4):559-63. PubMed ID: 20657225
[TBL] [Abstract][Full Text] [Related]
3. Relationship between self reporting of past history of anti-tuberculosis treatment and radiographic findings in multidrug-resistant tuberculosis.
Padayatchi N; Levin JB; Quantrill J
Int J Tuberc Lung Dis; 2004 Nov; 8(11):1385-7. PubMed ID: 15581211
[TBL] [Abstract][Full Text] [Related]
4. Radiographic findings and patterns in multidrug-resistant tuberculosis.
Fishman JE; Sais GJ; Schwartz DS; Otten J
J Thorac Imaging; 1998 Jan; 13(1):65-71. PubMed ID: 9440843
[TBL] [Abstract][Full Text] [Related]
5. The functional assessment of patients with pulmonary multidrug-resistant tuberculosis.
Godoy MD; Mello FC; Lopes AJ; Costa W; Guimarães FS; Pacheco AG; Castanho IA; Menezes SL
Respir Care; 2012 Nov; 57(11):1949-54. PubMed ID: 22417754
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of drug resistance in Thai human immunodeficiency virus seropositive tuberculosis patients.
Hongthiamthong P; Chuchottaworn C; Amatayakul N
J Med Assoc Thai; 1994 Jul; 77(7):363-7. PubMed ID: 7876754
[TBL] [Abstract][Full Text] [Related]
7. Post-tuberculous lung function impairment in a tuberculosis reference clinic in Cameroon.
Mbatchou Ngahane BH; Nouyep J; Nganda Motto M; Mapoure Njankouo Y; Wandji A; Endale M; Afane Ze E
Respir Med; 2016 May; 114():67-71. PubMed ID: 27109813
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment to increase the success rate of multidrug-resistant tuberculosis.
Man MA; Nicolau D
Eur J Cardiothorac Surg; 2012 Jul; 42(1):e9-12. PubMed ID: 22531273
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India.
Singla N; Singla R; Jain G; Habib L; Behera D
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1326-30. PubMed ID: 22283889
[TBL] [Abstract][Full Text] [Related]
11. Anti-tuberculosis drug resistance pattern among pulmonary tuberculosis patients with or without HIV infection in Mwanza, Tanzania.
Range N; Friis H; Mfaume S; Magnussen P; Chanualucha J; Kilale A; Mugomela A; Andersen AB
Tanzan J Health Res; 2012 Oct; 14(4):243-9. PubMed ID: 26591721
[TBL] [Abstract][Full Text] [Related]
12. Post treatment sequelae of multi-drug resistant tuberculosis patients.
Singla N; Singla R; Fernandes S; Behera D
Indian J Tuberc; 2009 Oct; 56(4):206-12. PubMed ID: 20469732
[TBL] [Abstract][Full Text] [Related]
13. Radiographic improvement and its predictors in patients with pulmonary tuberculosis.
Heo EY; Chun EJ; Lee CH; Kim YW; Han SK; Shim YS; Lee HJ; Yim JJ
Int J Infect Dis; 2009 Nov; 13(6):e371-6. PubMed ID: 19328733
[TBL] [Abstract][Full Text] [Related]
14. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.
Palmero DJ; Ambroggi M; Brea A; De Lucas M; Fulgenzi A; Martínez D; Mosca C; Musella R; Natiello M; Gonzalez C; Abbate E
Int J Tuberc Lung Dis; 2004 Jun; 8(6):778-84. PubMed ID: 15182150
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary tuberculosis: association between extent of the residual pulmonary lesion and alteration in the lung function].
Cruz Rde C; De Albuquerque Mde F; Campelo AR; Costa e Silva EJ; Mazza E; Menezes RC; Kosminsky S
Rev Assoc Med Bras (1992); 2008; 54(5):406-10. PubMed ID: 18989560
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
17. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
[TBL] [Abstract][Full Text] [Related]
18. Drug-resistant tuberculosis in South African gold miners: incidence and associated factors.
Churchyard GJ; Corbett EL; Kleinschmidt I; Mulder D; De Cock KM
Int J Tuberc Lung Dis; 2000 May; 4(5):433-40. PubMed ID: 10815737
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary function and respiratory health after successful treatment of drug-resistant tuberculosis.
Vashakidze SA; Kempker JA; Jakobia NA; Gogishvili SG; Nikolaishvili KA; Goginashvili LM; Magee MJ; Kempker RR
Int J Infect Dis; 2019 May; 82():66-72. PubMed ID: 30844519
[TBL] [Abstract][Full Text] [Related]
20. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
